Cancer, 113, 2221–43.
Albain K, Anderson S, Arriagada R, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet 2012;379(9814):432–44.
Audisio RA, Ramesh H, Longo WE, et al. Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist 2005;10:262–8.
Abe O, Abe R, Enomoto K, et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365(9472):1687–717.
Balducci L, Beghe C. Cancer and age in the USA. Crit Rev Oncol Hematol 2001;37: 137–45.
Balducci L. Geriatric oncology. Crit Rev Oncol Hematol 2003;46:211–20.
Balducci L, Cohen HJ, Engstrom PF, et al. Senior adult oncology clinical practice guidelines in oncology. J Natl Compr Canc Netw 2005;3:572–90.
Balducci L, Beghe C. Cancer in the elderly: biology, prevention, and treatment. In:Abeloff MD, Armitage JO, Niederhuber JE, et al, editors. Abeloff’s clinical oncology. 4th edition. Philadelphia: Churchill Livingstone; 2008. p. 1039–49.
Baker SD, Grochow LB. Pharmacology of cancer chemotherapy in the older person. Clin Geriatr Med 1997;13:169–83.
Burstein HJ, Prestrud AA, Seidenfeld J, et al. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 2010; 28(23):3784–96.
Chu KC, Tarone RE, Kessler LG, et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996;88:1571–9.
Chris E. Holmes MD, PhD; Hyman B. Muss, MD Breast Cancer in the Elderly // CA Cancer J Clin 2003;53:227–244 Volume 53 Y Number 4 Y July/August 2003.
Coleman MP et al. . Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol (2008), 9, 730–56.
Coates AS, Colleoni M, Goldhirsch A. Is adjuvant chemotherapy useful for women with luminal a breast cancer? J Clin Oncol 2012;30(12):1260–3.
Charlson M.E., Pompei P., Ales K.L., MacKenzie CR.: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 40(5):373-83, 1987.
Charlson M., Szatrowski T.P., Peterson J. and Gold J. J. Clin: Epidemiol 47: 1245-1251, 1994.
Christman K, Muss HB, Case LD, et al. Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience. JAMA 1992; 268(1):57–62 [see comment].
Dairkee SH, Mayall BH, Smith HS, Hackett AJ. Monoclonal marker that predicts early recurrence of breast cancer. Lancet. 1987 Feb 28;1(8531):514.
Danaei G et al. . Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet, 366, 1784–93. 2005
Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death:meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011; 378(9804):1707–16.
Dowsett M, Cuzick J, Wale C, et al. Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. J Clin Oncol 2010;28(11):1829–34.
Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000;92:550–556.
Durbecq V, Ameye L, Veys I, et al. A significant proportion of elderly patients develop hormone-dependent “luminal-B” tumours associated with aggressive characteristics. Crit Rev Oncol Hematol 2008;67:80–92.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005; 365: 1687–1717.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet 2008;371:29 – 40.
Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998;16:1582–7.
Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005;55:241–52.
Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007;25(14):1824–31.
Freyer G, Campone M, Peron J, et al. Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study. Crit Rev Oncol Hematol 2011;80(3):466–73.
Foulkes WD, Smith IE, Reis JS. Triple-negative breast cancer. N Engl J Med 2010;363(20):1938–48.
GarciaClosas M., Chanock S. Genetic susceptibility loci for breast cancer by estrogen receptor status // Clin Cancer Res.– 2008. – Vol.14, No2. – P.8000"8009.
GarciaClosas M., Hall P., Nevanlinna H., Pooley K. et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics // PLoS. Genet. – 2008. – Vol. 4(4). – P.1000054.
Geyer CE, Forster J, Lindquist D, et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 2006;355(26):2733–43.
Grant R. Williams, MDa, Ellen Jones, MD, PhDa, Hyman B. Muss, MD Challenges in the Treatment of Older Breast Cancer Patients Hematology/Oncology Clinics of North America Volume 27, Issue 4, August 2013, Pages 785–804
Gregor M, Zhang N, Niu J, et al. Trastuzumab-related cardiotoxicity among older breast cancer patients. ASCO Meeting Abstract. J Clin Oncol 2012;30(suppl 27): abstract 135.
Gridelli C. Same old story? Do we need to modify our supportive care treatment of elderly cancer patients? Focus on antiemetics. Drugs Aging 2004;21:825–32.
Herrinton LJ, Barlow WE, Yu O, et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 2005;23:4275–86.
Hind D, Wyld L, Reed MW. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review. Br J Cancer 2007;96:1025–9.
http://www.asco.org/press-center/asco-announces-press-program-2003-annual-meeting
http://www.who.int/mediacentre/factsheets/fs297/ru/
Hu Z., Fan C., Oh D.S., Marron J.S., He X., Qaqish B.F. et al. The molecular portraits of breast tumors are conserved across microarray platforms // BMC Genomics. – 2006. – Vol.7. – P.96.
Hurria A, Cirrincione CT, Muss HB, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 2011; 29(10):1290–6.
Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a Prospective Multicenter Study. J Clin Oncol 2011;29(25): 3457–65.
Hughes KS, Schnaper LA, Cirrincione C, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer. ASCO Meeting Abstracts. J Clin Oncol 2010;28(Suppl 15):abstract 507.
Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341:2061–7.
IARC . Breast cancer screening, IARC handbooks for cancer prevention, volume 7, Lyon, International Agency for Research on Cancer, IARCpress. 2002
IARC . World cancer report. Lyon, International Agency for Research on Cancer. 2008
International Breast Cancer Study Group, Rudenstam CM, Zahrieh D, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group. Trial 10-93. J Clin Oncol 2006;24:337–44.
Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2007. CA Cancer J Clin 57:43-66, 2007
Jones S, Holmes FA, O’Shaughnessy J, et al. Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US oncology research trial 9735. J Clin Oncol 2009;27(8):1177–83.
Kenis C, Schuermans H, Van Custem E, et al. Screening for a geriatric risk profile in older cancer patients: a comparative study of the predictive validity of three screening tools. Crit Rev Oncol Hematol 2009;72(Suppl):22.
Kemeny MM, Busch-Devereaux E, Merriam LT, et al. Cancer surgery in the elderly. Hematol Oncol Clin North Am 2000;14:169–92.
Lacey JV Jr. et al. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer, 9, 84. 2009 .
Laki F, Kirova Y, Savignoni A, et al. Management of operable invasive breast cancer in women over the age of 70: long term results of a large-scale single-institution experience. Ann Surg Oncol 2010;17:1530–8.
Lee S, Smith AK, Widera EW, et al. ePrognosis. 2012. Available at: http://www.eprognosis.org. Accessed February 12, 2013.
Lyman GH. Impact of chemotherapy dose intensity on cancer patient outcomes. J Natl Compr Canc Netw 2009;7(1):99–108.
Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003;21:1383–9.
Lostumbo L, Carbine N, Wallace J, et al. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 2004;4:CD002748.
Malzahn K, Mitze M, Thoenes M, Moll R. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virch Arch. 1998;433:119–129
Maggiore RJ, Gross CP, Hurria A. Polypharmacy in older adults with cancer.Oncologist 2010;15(5):507–22.
McCarthy EP, Burns RB, Freund KM, Ash AS, Shwartz M, Marwill SL, Moskowitz MA. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc. 2000 Oct;48(10):1226-33.
Miaskowski C, Shockney L, Chelbowski RT. Adherence to oral endocrine therapy for breast cancer: a nursing perspective. Clin J Oncol Nurs 2008;12(2):213–21.
Mohile SG, Fan L, Reeve E, et al. Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol 2011;29(11):1458–64.
Moll, R., Franke, W. W., Schiller, D. L., (1982). The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31, 11-24.
Muss HB, Berry DA, Cirrincione CT et al.; CALGB Investigators. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 2010;360:2055–2065.
Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005;293:1073–81.
Muss HB, Tu D, Ingle JN, et al. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17. J Clin Oncol 2008; 26(12):1956–64.
Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005;293(9): 1073–81.
Murphy CC, Bartholomew LK, Carpentier MY, et al. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 2012;134(2):459–78.
National Cancer Institute. Surveillance Epidemiology and End Results (SEER). Available at http://seer.cancer.gov/, accessed April 26, 2010.
Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA,Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.Clin Cancer Res. 2004 Aug 15;10(16):5367-74.
NCCN Clinical practice guidelines in oncology. Antiemesis, V.1.2012. Available at: http://www.nccn.org/professionals/physician_gls/PDF/ antiemesis.pdf.September 1, 2011.
Owusu C, Koroukian SM, Schluchter M, et al. Screening older cancer patients for a Comprehensive Geriatric Assessment: a comparison of three instruments. J Geriatr Oncol 2011;2:121–9.
Partridge AH, Archer L, Kornblith AB, et al. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol 2010;28:2418–22.
Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24(23):3726–34.
-
Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–752.
Peto J. . Cancer epidemiology in the last century and the next decade.
|
